← Back to Search

SNAPS intervention for Sexually Transmitted Diseases

N/A
Waitlist Available
Led By Robert Pitts, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up visits 3 months, 6 months, and 12 months
Awards & highlights

Study Summary

This trial will test an intervention to help people get and stay on PrEP, a medication that prevents HIV transmission, at a hospital in New York City.

Eligible Conditions
  • HIV (Human Immunodeficiency Virus)
  • Sexually Transmitted Diseases

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~visits 3 months, 6 months, and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and visits 3 months, 6 months, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in PrEP prescriptions
Change in the knowledge of HIV
Change in the number of HIV cases

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Pre- and Post- SNAPS interventionExperimental Treatment1 Intervention
In addition to the standard of care treatment, approximately twenty subjects will be selected for interview pre- and post-SNAPS intervention to assess PrEP facilitators and barriers for uptake. Participants of interest include cis- and trans-women, for which there is limited data regarding PrEP and HIV prevention.
Group II: Standard of CareActive Control1 Intervention
Participants will receive HIV and STI testing, clinical monitoring, client centered counseling and PrEP prescriptions as standard of care, this includes scheduled visits every three months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SNAPS intervention
2019
N/A
~200

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,366 Previous Clinical Trials
839,461 Total Patients Enrolled
Robert Pitts, MDPrincipal InvestigatorNew York University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining vacancies in this experiment for participants?

"As per clinicaltrials.gov, this experiment is not actively seeking participants at the moment; the initial posting was on July 22nd 2019 and it went through a last amendment on November 21st 2022. Nevertheless, 882 other experiments are presently welcoming volunteers."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Expanding PrEP By Embedding Unannounced SNAPS Navigators in High STI Testing Clinical Sites
2019. "Expanding PrEP By Embedding Unannounced SNAPS Navigators in High STI Testing Clinical Sites". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04207151.
~35 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top